FIELD: medicine.
SUBSTANCE: invention refers to new compounds of formula (I) 
where X is carboxylic acid, carboxylates, carboxylic anhydride, diglyceride, triglyceride, phospholipid, or carboxamides, or to any their pharmaceutically acceptable salt. The invention particularly refers to (4Z, 7Z, 10Z, 13Z, 16Z, 19Z)-ethyl 2-ethyldocosa-4,7,10,13,16,19-hexanoate. The invention also refers to a food lipid composition and to a composition for diabetes, for reducing insulin, blood glucose, plasma triglyceride, for dislipidemia, for reducing blood cholesterol, body weight and for peripheral insulin resistance, including such compounds. Besides, the invention refers to methods for treating and/or preventing diabetes, dislipidemia, peripheral insulin resistance, body weight reduction and/or weight gain prevention, insulin, blood cholesterol, blood glucose and/or plasma triglyceride reduction.
EFFECT: higher clinical effectiveness.
61 cl, 4 tbl, 16 dwg, 5 ex
| Title |
Year |
Author |
Number |
| ALPHA-SUBSTITUTED OMEGA-3 LIPIDS, ACTIVATORS OR MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) |
2007 |
- Brjun Morten
- Khol'Meide Anne Kristin
- Rosman Jenni
|
RU2507193C2 |
| CONJUGATED LIPID DERIVATIVES |
2007 |
|
RU2480447C2 |
| AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS |
2004 |
- Bush Brett
- Flehtt Brenton T.
- Gu Sjao-Khoj
- Martin Richard
- Mokhan Radzhu
- Van Te-Lin'
- Vu Dzhejson Kh.
|
RU2423363C2 |
| BORON-BASED SMALL MOLECULES AS ANTI-INFLAMMATORY DRUGS |
2007 |
- Bejker Stefen Dzh.
- Sanderz Virdzhinija
- Akama Tsutomu
- Bellinger-Kavakhara Kehrolin
- Frojnd Ivonne
- Mejplz Kerk R.
- Plattner Dzhejkob Dzh.
- Chzhan Jun-Kan
- Chzhou Khuchehn'
- Ehrnandes Vinsent S.
|
RU2508113C2 |
| BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS |
2007 |
- Bejker Stefen Dzh.
- Sanderz Virdzhiniya
- Akama Tsutomu
- Bellinger-Kavakhara Kerolin
- Frojnd Ivonne
- Mejplz Kerk R.
- Plattner Dzhejkob Dzh.
- Chzhan Yun-Kan
- Chzhou Khuchen
- Ernandes Vinsent S.
|
RU2642628C2 |
| DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTOR (PPARα) ACTIVATED BY PEROXISOME PROLIFERATORS, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR DYSLIPIDEMIA TREATMENT AND TYPE 2 DIABETES MELLITUS |
2002 |
- Al'Stermark Lindstedt Ehva-Lotte
- Ol'Sson Anna Kristina
- Li Lanna
|
RU2300517C2 |
| DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTORS ACTIVATED BY PEROXISOME PROLIFERATOR (PPARα), METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR TREATMENT OF DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2 |
2002 |
- Al'Stermark Lindstedt Ehva-Lotte
- Ol'Sson Anna Kristina
- Li Lanna
|
RU2303031C2 |
| NOVEL LIPID COMPOUNDS |
2007 |
- Khol'Meide Anne Kristin
- Rosman Jenni
|
RU2509071C2 |
| THERAPEUTIC AGENT FOR LIVER DISEASES |
2018 |
- Moon, Sung Hwan
- Lee, Soo Jin
- Lee, Sung Chan
- Bae, Yun Soo
|
RU2723686C1 |
| ORGANOSELENIUM COMPOUNDS AND THEIR USE |
2005 |
- Kang Kheondzoong
- Kham Dzungjeob
- Ko Dzaejang
- Khvang Khoosang
|
RU2371437C2 |
